HK1207883A1 - Cell culture method and utilization of the same - Google Patents

Cell culture method and utilization of the same

Info

Publication number
HK1207883A1
HK1207883A1 HK15108493.8A HK15108493A HK1207883A1 HK 1207883 A1 HK1207883 A1 HK 1207883A1 HK 15108493 A HK15108493 A HK 15108493A HK 1207883 A1 HK1207883 A1 HK 1207883A1
Authority
HK
Hong Kong
Prior art keywords
utilization
same
cell culture
culture method
cell
Prior art date
Application number
HK15108493.8A
Other languages
English (en)
Chinese (zh)
Inventor
后藤進
岸下昇也
田熊晉也
平島親
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1207883A1 publication Critical patent/HK1207883A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0031Serum-free culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15108493.8A 2005-01-05 2015-08-31 Cell culture method and utilization of the same HK1207883A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005000747 2005-01-05

Publications (1)

Publication Number Publication Date
HK1207883A1 true HK1207883A1 (en) 2016-02-12

Family

ID=36647552

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108493.8A HK1207883A1 (en) 2005-01-05 2015-08-31 Cell culture method and utilization of the same

Country Status (16)

Country Link
US (1) US9714410B2 (fr)
EP (2) EP1835022B1 (fr)
JP (1) JP4818936B2 (fr)
KR (2) KR20130101161A (fr)
CN (2) CN101061215A (fr)
AU (1) AU2005323643B2 (fr)
CA (1) CA2593521C (fr)
DK (1) DK1835022T3 (fr)
ES (1) ES2535230T3 (fr)
HK (1) HK1207883A1 (fr)
IL (1) IL184262A (fr)
MX (1) MX2007007842A (fr)
PL (1) PL1835022T3 (fr)
SI (1) SI1835022T1 (fr)
TW (1) TWI409332B (fr)
WO (1) WO2006073070A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312184T3 (es) 1997-03-21 2009-02-16 Chugai Seiyaku Kabushiki Kaisha Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas.
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
EP2311489A3 (fr) 2002-02-14 2013-08-21 Chugai Seiyaku Kabushiki Kaisha Formulation des solutions contenant des anti-corps comportant un sucre comme stabilisateur
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
WO2005090405A1 (fr) 2004-03-24 2005-09-29 Chugai Seiyaku Kabushiki Kaisha Sous-type d'anticorps humanisé contre un récepteur de l'interleukine-6
EP2041259B1 (fr) * 2006-07-14 2015-10-14 DPx Holdings B.V. Processus amélioré de culture de cellules
PE20091174A1 (es) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
DK2130906T3 (da) * 2008-06-04 2014-05-12 Biosilta Oy Fremgangsmåde til tilførsel af vækstkomponenter til cellekulturer
JP5711751B2 (ja) 2009-10-26 2015-05-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft グリコシル化された免疫グロブリンの調製方法
MX2013005024A (es) 2010-11-08 2013-11-21 Chugai Pharmaceutical Co Ltd Anticuerpo anti-il-6 receptor administrado subcutaneamente.
CA2913687C (fr) 2013-07-04 2022-12-13 F. Hoffmann-La Roche Ag Dosage immunologique a interference supprime et pour detecter des anticorps anti-medicament dans des echantillons de serum
WO2016085787A1 (fr) 2014-11-25 2016-06-02 Corning Incorporated Matériaux et procédés d'extension de milieux de culture cellulaire
AR104050A1 (es) * 2015-03-26 2017-06-21 Chugai Pharmaceutical Co Ltd Proceso de producción con iones de cobre controlados
WO2017147169A1 (fr) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chimioprévention utilisant des formulations à libération contrôlée d'agents anti-interleukine 6, d'analogues ou des métabolites synthétiques de la vitamine a et de métabolites de l'œstradiol
WO2018170405A1 (fr) 2017-03-17 2018-09-20 Ohio State Innovation Foundation Nanoparticules pour l'administration d'agents chimiopréventifs
JP2022527972A (ja) 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632065B2 (en) 1988-09-23 1992-12-17 Novartis Vaccines And Diagnostics, Inc. Cell culture medium for enhanced cell growth, culture longevity and product expression
AU668349B2 (en) 1991-04-25 1996-05-02 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin 6 receptor
US5426045A (en) * 1993-12-16 1995-06-20 Sea Run Holdings, Inc. Method for culturing mammalian cells in a medium containing fish serum
WO1995023212A1 (fr) * 1994-02-23 1995-08-31 Sea Run Holdings, Inc. Procede pour cultiver des cellules de mammiferes et d'insectes dans un milieu contenant du serum de poissons
US5498540A (en) * 1994-02-23 1996-03-12 Sea Run Holdings, Inc. Method for culturing insect cells in a medium containing fish serum
US5401653A (en) * 1994-02-23 1995-03-28 Sea Run Holdings, Inc. Method for culturing insect cells in a medium containing fish serum
US5443894A (en) * 1994-07-29 1995-08-22 Ucar Carbon Technology Corporation Fire retardant oriented strand board structure element
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
US6537782B1 (en) * 1998-06-01 2003-03-25 Chugai Seiyaku Kabushiki Kaisha Media for culturing animal cells and process for producing protein by using the same
CA2417689C (fr) * 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Methodes ameliorees de culture in vitro de cellules de mammiferes
JP3822137B2 (ja) 2002-05-20 2006-09-13 中外製薬株式会社 動物細胞培養用培地の添加剤およびそれを用いたタンパク質の製造方法
ATE414144T1 (de) * 2003-05-09 2008-11-15 Crucell Holland Bv Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
JP4353731B2 (ja) 2003-06-10 2009-10-28 前澤工業株式会社 溶液中のヒ素の除去方法
JP5452835B2 (ja) * 2003-07-15 2014-03-26 中外製薬株式会社 形質転換細胞によるIgMの産生とその定量方法
TW200530269A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies

Also Published As

Publication number Publication date
JPWO2006073070A1 (ja) 2008-06-12
TWI409332B (zh) 2013-09-21
AU2005323643B2 (en) 2011-07-21
WO2006073070A1 (fr) 2006-07-13
DK1835022T3 (en) 2015-02-23
EP1835022B1 (fr) 2015-02-11
KR101573529B1 (ko) 2015-12-01
IL184262A0 (en) 2007-10-31
CA2593521C (fr) 2016-06-21
EP1835022A4 (fr) 2009-11-11
MX2007007842A (es) 2007-08-21
ES2535230T3 (es) 2015-05-06
CN104651295A (zh) 2015-05-27
EP2843040A1 (fr) 2015-03-04
CN101061215A (zh) 2007-10-24
PL1835022T3 (pl) 2015-06-30
SI1835022T1 (sl) 2015-04-30
JP4818936B2 (ja) 2011-11-16
CA2593521A1 (fr) 2006-07-13
EP1835022A1 (fr) 2007-09-19
KR20130101161A (ko) 2013-09-12
US9714410B2 (en) 2017-07-25
AU2005323643A1 (en) 2006-07-13
IL184262A (en) 2015-09-24
US20080124761A1 (en) 2008-05-29
KR20070090998A (ko) 2007-09-06
TW200636068A (en) 2006-10-16

Similar Documents

Publication Publication Date Title
HK1207883A1 (en) Cell culture method and utilization of the same
EP1988153A4 (fr) Recipient de culture cellulaire et son procede de production
EP2189519A4 (fr) Instrument de culture cellulaire et procédé de culture cellulaire l'utilisant
EP1775341A4 (fr) Procédé pour induire la différenciation de cellules d'origine amniotique, et utilisation correspondante
EP2089507A4 (fr) Dispositifs et procédés particulièrement efficaces dans la culture de cellules
EP1855325A4 (fr) Cellule solaire et procede de fabrication idoine
GB2446525B (en) Stem cell culture medium and method
EP1909097A4 (fr) Biocapteur et cellule à biocapteur
EP1946393A4 (fr) Conception d'element de batterie et procede de construction de celle-ci
EP2014763A4 (fr) Recipient destine a la culture cellulaire et son procede de production
EP1978089A4 (fr) Procédé de culture cellulaire et système de culture automatique utilisant ce procédé
IL190546A0 (en) Method of cell cultures and device for implementing it
EP1815244A4 (fr) Dispositif de culture de cellules
GB0524075D0 (en) Electrochemical cell and method of manufacture
GB0524077D0 (en) Electrochemical cell and method of manufacture
IL182940A0 (en) Solid electrolyte and method of producing the same
EP2064324A4 (fr) Substrats utiles pour une culture de cellules, et leurs procédés de fabrication et d'utilisation
EP1970443A4 (fr) Support permettant de préparer une enzyme immobilisée ou des cellules immobilisées et procédé d'utilisation de celui-ci
EP1906468A4 (fr) Boîtier de batterie et son procédé de fabrication
GB0525579D0 (en) Cell culture vessel
EP1743025A4 (fr) Techniques de production de lymphocytes t regulateurs et utilisation de ceux-ci
GB0517382D0 (en) Cell culture
EP1935974A4 (fr) Cuve de culture et procédé de culture
ZA200901914B (en) Stem cell culture medium and method
GB2404665B (en) Cell culture